Drug Profile
RG 7256
Alternative Names: PLX-3603; RG7256; RO-5212054Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Plexxikon
- Developer Plexxikon; Roche
- Class Antineoplastics; Pyridines; Pyrroles; Small molecules; Sulfonamides
- Mechanism of Action Proto oncogene protein b raf inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Colorectal cancer; Malignant melanoma; Solid tumours
Most Recent Events
- 16 Oct 2012 Discontinued - Phase-I for Colorectal cancer in Australia (PO)
- 16 Oct 2012 Discontinued - Phase-I for Colorectal cancer in Denmark (PO)
- 16 Oct 2012 Discontinued - Phase-I for Colorectal cancer in Spain (PO)